157 related articles for article (PubMed ID: 9177441)
1. No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes.
Mitani K; Hangaishi A; Imamura N; Miyagawa K; Ogawa S; Kanda Y; Yazaki Y; Hirai H
Leukemia; 1997 Jun; 11(6):863-5. PubMed ID: 9177441
[TBL] [Abstract][Full Text] [Related]
2. Oncogene mutation and prognosis in the myelodysplastic syndromes.
Padua RA; West RR
Br J Haematol; 2000 Dec; 111(3):873-4. PubMed ID: 11122149
[TBL] [Abstract][Full Text] [Related]
3. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
4. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation in the myelodysplastic syndromes.
Adamson DJ; Dawson AA; Bennett B; King DJ; Haites NE
Br J Haematol; 1995 Jan; 89(1):61-6. PubMed ID: 7833278
[TBL] [Abstract][Full Text] [Related]
6. P53 mutations in myelodysplastic syndromes.
Ludwig L; Schulz AS; Janssen JW; Grünewald K; Bartram CR
Leukemia; 1992 Dec; 6(12):1302-4. PubMed ID: 1453775
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia.
Mori N; Hidai H; Yokota J; Okada M; Motoji T; Oshimi K; Mizoguchi H
Leuk Res; 1995 Nov; 19(11):869-75. PubMed ID: 8551805
[TBL] [Abstract][Full Text] [Related]
8. Codon 12 ras mutations in patients with myelodysplastic syndrome: incidence and prognostic value.
Constantinidou M; Chalevelakis G; Economopoulos T; Koffa M; Liloglou T; Anastassiou C; Yalouris A; Spandidos DA; Raptis S
Ann Hematol; 1997 Jan; 74(1):11-4. PubMed ID: 9031609
[TBL] [Abstract][Full Text] [Related]
9. Analysis of immunohistochemical results of the ras oncogene product p21 in myelodysplastic syndromes.
Kalmantis T; Kalmanti M; Vassilaki M; Spandidos DA
Anticancer Res; 1993; 13(4):1103-6. PubMed ID: 8352532
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H
Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529
[TBL] [Abstract][Full Text] [Related]
11. A case of refractory anaemia with p53 point mutation at codon 249 (AGG to ATG).
Kikukawa M; Aoki N; Mori M
Br J Haematol; 1996 Mar; 92(4):831-3. PubMed ID: 8616074
[TBL] [Abstract][Full Text] [Related]
12. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
Kurosawa M
Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
[TBL] [Abstract][Full Text] [Related]
13. Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing.
Bar-Eli M; Ahuja H; Gonzalez-Cadavid N; Foti A; Cline MJ
Blood; 1989 Jan; 73(1):281-3. PubMed ID: 2642713
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes.
Hofmann WK; Takeuchi S; Xie D; Miller CW; Hoelzer D; Koeffler HP
Leuk Res; 2001 Oct; 25(10):855-8. PubMed ID: 11532517
[TBL] [Abstract][Full Text] [Related]
15. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
Werner M; Maschek H; Kaloutsi V; Choritz H; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.
Neubauer A; Greenberg P; Negrin R; Ginzton N; Liu E
Leukemia; 1994 Apr; 8(4):638-41. PubMed ID: 7512175
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
Sugimoto K; Hirano N; Toyoshima H; Chiba S; Mano H; Takaku F; Yazaki Y; Hirai H
Blood; 1993 Jun; 81(11):3022-6. PubMed ID: 8499637
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
20. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
